BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15114094)

  • 1. Hepatitic graft-versus-host disease after hematopoietic stem cell transplantation: clinicopathologic features and prognostic implication.
    Ma SY; Au WY; Ng IO; Lie AK; Leung AY; Liang R; Lau GK; Kwong YL
    Transplantation; 2004 Apr; 77(8):1252-9. PubMed ID: 15114094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitic Variant of Graft-vs-Host Disease.
    Liang TZ; Dong S; Fang M; Gong Y; Yaghmour G; Chopra S
    Am J Clin Pathol; 2022 Jun; 157(6):948-955. PubMed ID: 35038720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitic variant of graft-versus-host disease after donor lymphocyte infusion.
    Akpek G; Boitnott JK; Lee LA; Hallick JP; Torbenson M; Jacobsohn DA; Arai S; Anders V; Vogelsang GB
    Blood; 2002 Dec; 100(12):3903-7. PubMed ID: 12393729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation.
    Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL
    Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of bilirubin and liver enzymes is useful for predicting of liver graft-versus-host disease.
    Krejci M; Kamelander J; Pospisil Z; Mayer J
    Neoplasma; 2012; 59(3):264-8. PubMed ID: 22296496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation.
    Fujii N; Takenaka K; Shinagawa K; Ikeda K; Maeda Y; Sunami K; Hiramatsu Y; Matsuo K; Ishimaru F; Niiya K; Yoshino T; Hirabayashi N; Harada M
    Bone Marrow Transplant; 2001 May; 27(9):1007-10. PubMed ID: 11436113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperbilirubinemia after hematopoietic stem cell transplantation: comparison of clinical and pathologic findings in 41 autopsied cases.
    Kagoya Y; Takahashi T; Nannya Y; Shinozaki A; Ota S; Fukayama M; Kurokawa M
    Clin Transplant; 2011; 25(5):E552-7. PubMed ID: 21919962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.
    El-Sayed MH; El-Haddad A; Fahmy OA; Salama II; Mahmoud HK
    Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1347-54. PubMed ID: 15618844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitic pattern of graft versus host disease in children.
    Melín-Aldana H; Thormann K; Duerst R; Kletzel M; Jacobsohn DA
    Pediatr Blood Cancer; 2007 Oct; 49(5):727-30. PubMed ID: 17066458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients.
    Liao YP; Jiang JL; Zou WY; Xu DR; Li J
    World J Gastroenterol; 2015 Apr; 21(14):4284-92. PubMed ID: 25892880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic graft-versus-host disease after hematopoietic cell transplantation presenting as an acute hepatitis.
    Malik AH; Collins RH; Saboorian MH; Lee WM
    Am J Gastroenterol; 2001 Feb; 96(2):588-90. PubMed ID: 11232714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of liver biopsy in the management of liver dysfunction after hematopoietic stem-cell transplantation in a hepatitis B virus-prevalent patient population.
    Ma SY; Au WY; Ng IO; Lie AK; Leung AY; Liang RH; Lau GK; Kwong YL
    Transplantation; 2003 Jul; 76(1):169-76. PubMed ID: 12865805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Study on the damage of liver in patients with SARS].
    Guan YJ; Tang XP; Yin CB; Yi ZQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 May; 16(5):267-70. PubMed ID: 15132787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum 5'nucleotidase and alkaline phosphatase--highly predictive liver function tests for the diagnosis of graft-versus-host disease in bone marrow transplant recipients.
    Yasmineh WG; Filipovich AH; Killeen AA
    Transplantation; 1989 Nov; 48(5):809-14. PubMed ID: 2554545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of acute liver "graft-versus-host disease" following allogeneic myeloablative stem cell transplant].
    Doki N; Saito Y; Hatsumi N; Irisawa H; Sakura T; Miyawaki S
    Rinsho Ketsueki; 2004 Jan; 45(1):57-60. PubMed ID: 14999935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
    Ruutu T; Eriksson B; Remes K; Juvonen E; Volin L; Remberger M; Parkkali T; Hägglund H; Ringdén O;
    Blood; 2002 Sep; 100(6):1977-83. PubMed ID: 12200355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment of steroid-refractory hepatitic variant of liver graft-vs-host disease with pulse cyclophosphamide.
    Mayer J; Krejci M; Pospisil Z; Doubek M; Janikova A; Zackova D; Racil Z; Smardova L; Navratil M; Kamelander J
    Exp Hematol; 2009 Jun; 37(6):767-73. PubMed ID: 19463776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis.
    Strasser SI; Shulman HM; Flowers ME; Reddy R; Margolis DA; Prumbaum M; Seropian SE; McDonald GB
    Hepatology; 2000 Dec; 32(6):1265-71. PubMed ID: 11093733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries.
    Kwo PY; Cohen SM; Lim JK
    Am J Gastroenterol; 2017 Jan; 112(1):18-35. PubMed ID: 27995906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.